Cardio Diagnostics Holdings annual capital expenditures (capex)
2021
2022
2023
2024
2025
Cardio Diagnostics Holdings Capital Expenditures (CapEx) Growth & History (CDIO)
Cardio Diagnostics Holdings's capital expenditures (capex) was $187,317 for fiscal 2025.
View full Cardio Diagnostics Holdings company overviewCardio Diagnostics Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $187,317 | −$27,448 | −12.78% |
| 2024 | 2024-12-31 | $214,765 | −$360,898 | −62.69% |
| 2023 | 2023-12-31 | $575,663 | $499,509 | +655.92% |
| 2022 | 2022-12-31 | $76,154 | −$37,875 | −33.22% |
| 2021 | 2021-12-31 | $114,029 | — | — |
Cardio Diagnostics Holdings quarterly capital expenditures (capex)
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$18,696 | — |
| Q1 2026 | 2026-03-31 | $1,760 | −$4,027 | −69.59% |
| Q4 2025 | 2025-12-31 | $0 | −$3,638 | — |
| Q3 2025 | 2025-09-30 | $162,834 | $139,588 | +600.48% |
| Q2 2025 | 2025-06-30 | $18,696 | −$149,200 | −88.86% |
| Q1 2025 | 2025-03-31 | $5,787 | −$14,198 | −71.04% |
| Q4 2024 | 2024-12-31 | $3,638 | −$445,180 | −99.19% |
| Q3 2024 | 2024-09-30 | $23,246 | $10,655 | +84.62% |
| Q2 2024 | 2024-06-30 | $167,896 | $106,316 | +172.65% |
| Q1 2024 | 2024-03-31 | $19,985 | −$32,689 | −62.06% |
| Q4 2023 | 2023-12-31 | $448,818 | $411,270 | +1095.32% |
| Q3 2023 | 2023-09-30 | $12,591 | $12,591 | — |
| Q2 2023 | 2023-06-30 | $61,580 | $39,410 | +177.76% |
| Q1 2023 | 2023-03-31 | $52,674 | $36,238 | +220.48% |
| Q4 2022 | 2022-12-31 | $37,548 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q2 2022 | 2022-06-30 | $22,170 | — | — |
| Q1 2022 | 2022-03-31 | $16,436 | — | — |
Cardio Diagnostics Holdings capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Cardio Diagnostics Holdings's capital expenditures (capex) increased from $114,029 to $187,317, a change of $73,288. The latest reported quarter, Q2 2026, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardio Diagnostics Holdings source filings ↗